BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 21666962)

  • 1. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
    Viana Abranches M; Esteves de Oliveira FC; Bressan J
    Nutr Hosp; 2011; 26(2):271-9. PubMed ID: 21666962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].
    Alemán G; Torres N; Tovar AR
    Rev Invest Clin; 2004; 56(3):351-67. PubMed ID: 15612519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
    Tjokroprawiro A
    Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB; Lichnovská R; Brychta T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):237-41. PubMed ID: 16601762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PPAR and diabetes].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2005 Apr; 63(4):623-9. PubMed ID: 15828230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
    Andrééva-Gatéva P
    Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARs and the kidney in metabolic syndrome.
    Ruan X; Zheng F; Guan Y
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
    Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
    Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity.
    Spiegelman BM
    Eur J Med Res; 1997 Nov; 2(11):457-64. PubMed ID: 9385114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
    Kravchenko NA; Iarmysh NV
    Tsitol Genet; 2011; 45(3):68-78. PubMed ID: 21774406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selected pathophysiological aspects of PPARs activation.
    Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
    J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    Guan Y
    J Am Soc Nephrol; 2004 Nov; 15(11):2801-15. PubMed ID: 15504933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARs and their effects on the cardiovascular system.
    Oyekan A
    Clin Exp Hypertens; 2011; 33(5):287-93. PubMed ID: 21721973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
    Chinetti-Gbaguidi G; Fruchart JC; Staels B
    Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
    Uauy R; Martínez JI; Rojas CV
    Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity.
    Shao X; Wang M; Wei X; Deng S; Fu N; Peng Q; Jiang Y; Ye L; Xie J; Lin Y
    Curr Stem Cell Res Ther; 2016; 11(3):282-9. PubMed ID: 26018229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
    Takahashi N; Goto T; Kusudo T; Moriyama T; Kawada T
    Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    Clin Nutr; 2006 Dec; 25(6):871-85. PubMed ID: 17052808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.